# Methyl Sinapate (Phenolic Ester)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/methyl-sinapate
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Compound
**Also Known As:** 4-hydroxy-3,5-dimethoxycinnamate methyl ester, methyl 3,5-dimethoxy-4-hydroxycinnamate, sinapic acid methyl ester, MS, methyl 4-hydroxy-3,5-dimethoxycinnamate, phenolic ester compound C12H14O5

## Overview

Methyl sinapate is a phenolic ester compound found naturally in certain plants, particularly mustard seeds and canola oil. Current evidence is limited to preclinical studies showing interactions with MAPK/ERK and [NF-κB](/ingredients/condition/inflammation) signaling pathways.

## Health Benefits

• No clinically proven health benefits - evidence limited to preclinical studies only
• Associated with increased chromosome aberrations in cells (preliminary evidence)
• Linked to multiple biochemical pathways including MAPK/ERK and [NF-κB](/ingredients/condition/inflammation) in research contexts (mechanism studies only)
• May interact with PI3K/Akt/mTOR and neuronal signaling pathways (theoretical, no clinical evidence)
• No human studies available to confirm any therapeutic effects

## Mechanism of Action

Methyl sinapate appears to modulate the MAPK/ERK signaling pathway, which regulates cell proliferation and differentiation. The compound also interacts with NF-κB pathways involved in [inflammatory](/ingredients/condition/inflammation) responses. However, preliminary evidence suggests it may increase chromosome aberrations in cellular studies, indicating potential genotoxic effects.

## Clinical Summary

No human clinical trials have been conducted on methyl sinapate supplementation. Available research consists entirely of in vitro cell culture studies and animal models examining its biochemical effects. Preliminary cellular studies have raised safety concerns due to observed increases in chromosome aberrations. The lack of clinical data makes it impossible to establish efficacy or safe dosing parameters for human use.

## Nutritional Profile

Methyl Sinapate is a phenolic ester compound (methyl ester of sinapic acid), not a nutritional ingredient and therefore carries no meaningful macronutrient or micronutrient profile in the dietary sense. Molecular formula: C12H14O5, molecular weight: 238.24 g/mol. Bioactive compound classification: hydroxycinnamic acid derivative (phenylpropanoid family), structurally characterized by a methoxylated and hydroxylated cinnamic acid backbone esterified with a methyl group. Contains two methoxy groups (-OCH3) at the 3 and 5 positions and one hydroxyl group (-OH) at the 4 position of the aromatic ring. Protein content: 0g. Fat content: 0g. Carbohydrate content: 0g. Fiber: 0g. Caloric value: negligible/not applicable as a food ingredient. Naturally occurring trace concentrations found in Brassica species (mustard, rapeseed, canola) and related plant sources, typically at sub-milligram per gram levels in plant tissue. Bioavailability: limited data available; as a phenolic ester, subject to esterase hydrolysis in the gastrointestinal tract potentially releasing sinapic acid as the primary bioactive metabolite. Lipophilicity (logP estimated ~1.5–2.0) suggests moderate membrane permeability. No established dietary reference intake, no RDA, and no recognized role as an essential nutrient. [Antioxidant](/ingredients/condition/antioxidant) capacity attributed to the phenolic hydroxyl group, consistent with other sinapate esters, though quantitative ORAC or DPPH values specific to methyl sinapate in food matrices are not established in published literature.

## Dosage & Preparation

No clinically studied dosage ranges have been established for methyl sinapate as no human clinical trials exist. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Methyl sinapate shows concerning preliminary evidence of increased chromosome aberrations in cell studies, suggesting potential genotoxic effects. No human safety data exists, and interactions with medications are unknown due to lack of clinical research. Pregnant and breastfeeding women should avoid this compound due to insufficient safety information. The compound's effects on drug [metabolism](/ingredients/condition/weight-management) pathways remain unstudied.

## Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses on methyl sinapate have been identified. Research is limited to in vitro or preclinical studies examining its association with chromosome aberrations and biochemical pathway interactions.

## Historical & Cultural Context

No historical or traditional medicinal uses of methyl sinapate are documented in available sources. The compound has not been associated with any traditional medicine systems such as Ayurveda or TCM.

## Synergistic Combinations

Not applicable - no established therapeutic use

## Frequently Asked Questions

### What foods contain methyl sinapate naturally?

Methyl sinapate is found primarily in mustard seeds and canola oil. It also occurs in smaller amounts in other cruciferous vegetables and their derived oils.

### Is methyl sinapate safe to take as a supplement?

Safety is unknown as no human studies exist. Preliminary cell studies show concerning chromosome aberration increases, suggesting potential genotoxic effects that warrant caution.

### What is the recommended dosage for methyl sinapate?

No recommended dosage exists since methyl sinapate lacks clinical trials in humans. Without safety and efficacy data, no scientific basis exists for supplement dosing recommendations.

### Does methyl sinapate have anti-inflammatory properties?

Laboratory studies show methyl sinapate interacts with NF-κB pathways involved in inflammation. However, no clinical evidence demonstrates actual anti-inflammatory benefits in humans.

### Can methyl sinapate cause chromosome damage?

Preliminary cell culture studies indicate methyl sinapate may increase chromosome aberrations. While concerning, this evidence is limited to laboratory conditions and requires further research to determine human relevance.

### What does the research say about methyl sinapate's clinical evidence in humans?

Currently, there are no clinical trials demonstrating health benefits of methyl sinapate in humans—all evidence comes from laboratory and preclinical studies on cells and animal models. While research has identified potential biochemical pathways methyl sinapate may influence (such as MAPK/ERK and NF-κB signaling), these findings have not been translated into proven therapeutic effects in people. The gap between preclinical promise and human clinical validation remains significant for this compound.

### Who should avoid methyl sinapate supplementation based on current evidence?

Given preliminary findings linking methyl sinapate to increased chromosome aberrations in cellular studies, individuals concerned about genetic stability—particularly pregnant women, nursing mothers, and those with pre-existing genetic conditions—should consult a healthcare provider before supplementation. The absence of long-term human safety data and lack of established clinical benefit make it difficult to recommend this ingredient to any population at present.

### How does methyl sinapate's bioavailability compare to other phenolic esters?

There is insufficient human research comparing the absorption and bioavailability of methyl sinapate to other phenolic compounds or ester forms. Most bioavailability data for methyl sinapate comes from in vitro or animal studies, which cannot reliably predict how well humans absorb or utilize this compound. Direct human bioavailability studies would be needed to determine optimal forms and absorption conditions for supplementation.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*